Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reconsolidation intervention with propranolol for combat-related PTSD
2020-000934-16Phase 4Active
- Sponsor
- TNO
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of propranolol in post-traumatic stress disorder (PTSD), sponsored by TNO. Primary endpoints: Percent change in PTSD diagnosis and Decrease in frequency and severity of PTSD symptoms. Started Jun 2020; status: active.
02
Drugs
propranolol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on 2020-000934-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000934-16.